Literature DB >> 15616286

Identification of novel inhibitors of bacterial translation elongation factors.

Maithri M K Jayasekera1, Keysha Onheiber, John Keith, Hariharan Venkatesan, Alejandro Santillan, Emily M Stocking, Liu Tang, Jennifer Miller, Leslie Gomez, Brooke Rhead, Tavner Delcamp, Shaoming Huang, Ronald Wolin, Ekaterina V Bobkova, Karen Joy Shaw.   

Abstract

Bacterial elongation factor Tu (EF-Tu) and EF-Ts are interacting proteins involved in polypeptide chain elongation in protein biosynthesis. A novel scintillation proximity assay for the detection of inhibitors of EF-Tu and EF-Ts, as well as the interaction between them, was developed and used in a high-throughput screen of a chemical library. Several compounds from a variety of chemical series with inhibitory properties were identified, including certain indole dipeptides, benzimidazole amidines, 2-arylbenzimidazoles, N-substituted imidazoles, and N-substituted guanidines. The in vitro activities of these compounds were confirmed in a coupled bacterial transcription-translation assay. Several indole dipeptides were identified as inhibitors of bacterial translation, with compound 2 exhibiting a 50% inhibitory concentration of 14 microM and an MIC for S. aureus ATCC 29213 of 5.6 microg/ml. Structure-activity relationship studies around the dipeptidic indoles generated additional analogs with low micromolar MICs for both gram-negative and gram-positive bacteria. To assess the specificity of antibacterial action, these compounds were evaluated in a metabolic labeling assay with Staphylococcus aureus. Inhibition of translation, as well as limited effects on other macromolecular pathways for some of the analogs studied, indicated a possible contribution from a non-target-based antibacterial mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616286      PMCID: PMC538871          DOI: 10.1128/AAC.49.1.131-136.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Identification of inhibitors of bacterial transcription/translation machinery utilizing a miniaturized 1536-well format screen.

Authors:  I Kariv; H Cao; P D Marvil; E V Bobkova; Y E Bukhtiyarov; Y P Yan; U Patel; L Coudurier; T D Chung; K R Oldenburg
Journal:  J Biomol Screen       Date:  2001-08

2.  Conformational change of elongation factor Tu (EF-Tu) induced by antibiotic binding. Crystal structure of the complex between EF-Tu.GDP and aurodox.

Authors:  L Vogeley; G J Palm; J R Mesters; R Hilgenfeld
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

3.  An alpha to beta conformational switch in EF-Tu.

Authors:  K Abel; M D Yoder; R Hilgenfeld; F Jurnak
Journal:  Structure       Date:  1996-10-15       Impact factor: 5.006

4.  Mutational analysis of the roles of residues in Escherichia coli elongation factor Ts in the interaction with elongation factor Tu.

Authors:  Y Zhang; N J Yu; L L Spremulli
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

5.  The importance of structural transitions of the switch II region for the functions of elongation factor Tu on the ribosome.

Authors:  C Knudsen; H J Wieden; M V Rodnina
Journal:  J Biol Chem       Date:  2001-04-13       Impact factor: 5.157

6.  Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.

Authors:  S E Heffron; F Jurnak
Journal:  Biochemistry       Date:  2000-01-11       Impact factor: 3.162

7.  Separation of three microbial amino acid polymerization factors.

Authors:  J Lucas-Lenard; F Lipmann
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

8.  The structure of the Escherichia coli EF-Tu.EF-Ts complex at 2.5 A resolution.

Authors:  T Kawashima; C Berthet-Colominas; M Wulff; S Cusack; R Leberman
Journal:  Nature       Date:  1996-02-08       Impact factor: 49.962

9.  Elongation factor Ts of Chlamydia trachomatis: structure of the gene and properties of the protein.

Authors:  Y Zhang; J Tao; M Zhou; Q Meng; L Zhang; L Shen; R Klein; D L Miller
Journal:  Arch Biochem Biophys       Date:  1997-08-01       Impact factor: 4.013

10.  Crystal structure of the ternary complex of Phe-tRNAPhe, EF-Tu, and a GTP analog.

Authors:  P Nissen; M Kjeldgaard; S Thirup; G Polekhina; L Reshetnikova; B F Clark; J Nyborg
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

View more
  4 in total

Review 1.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 2.  Antibacterials Developed to Target a Single Organism: Mechanisms and Frequencies of Reduced Susceptibility to the Novel Anti-Clostridium difficile Compounds Fidaxomicin and LFF571.

Authors:  Jennifer A Leeds
Journal:  Cold Spring Harb Perspect Med       Date:  2016-02-01       Impact factor: 6.915

3.  1-Methyl-2-({[(1-methyl-1H-benzimid-azol-2-yl)meth-yl](phen-yl)amino}-meth-yl)1H-benzimidazol-3-ium picrate.

Authors:  Bin Liu; Fan Kou; Fei Jia; Jingkui Yuan; Huilu Wu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-25

4.  Cloning and characterization of EF-Tu and EF-Ts from Pseudomonas aeruginosa.

Authors:  Stephanie O Palmer; Edna Y Rangel; Alberto E Montalvo; Alexis T Tran; Kate C Ferguson; James M Bullard
Journal:  Biomed Res Int       Date:  2013-08-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.